Carver Thesis Tracker
Bullish/bearish reads aggregated from Carver-annotated regulatory events
-
A
DEA lowers schedule for marijuana ↑ 0 ↓ 0 direct
By Dec 31, 2026, 11:59 PM ET, a final DEA action reclassifies marijuana (the whole plant/substance, i.e., recreational marijuana) from Schedule I to II–V. Not satisfied by rescheduling only cannabinoids/derivatives.
-
B
DEA unschedules marijuana ↑ 0 ↓ 0 direct
By Dec 31, 2026, 11:59 PM ET, a final DEA action removes marijuana entirely from the Controlled Substances Act schedules (unscheduled).
Carver Signal Narrative
Regulatory pressure centers on DEA’s rescheduling rulemaking, but 2025–26 developments—state AG crackdowns, a multistate letter on federal-state enforcement, and OFAC fentanyl sanctions—are peripheral and offer no clear signal. The key federal decision remains pending; a final DEA action is still needed before the Dec 31, 2026 deadline.
Settlement entities
Regulatory timeline (5)
-
→ neutral ○ ContextTreasury Disrupts Sinaloa Cartel Narco-Terrorist Fentanyl Trafficking Operations
OFAC sanctions targeting Sinaloa fentanyl trafficking are unrelated to DEA action on marijuana rescheduling, so no material effect on the outcome.
-
→ neutral ○ ContextAttorney General Bonta: Joint Investigation Leads to Felony Charges Against Unlicensed Cannabis Retailer for $7.1 Million in Tax Evasion - 13.05.2026
State tax prosecution of an unlicensed cannabis retailer is a local enforcement action and has no clear effect on the DEA's federal rescheduling decision.
-
→ neutral ○ ContextAttorney General Alan Wilson announces indictments in State Grand Jury Operation ‘Ganjapreneur’ involving marijuana and illegal THC products being sold openly in SC businesses
South Carolina Attorney General — State Grand Jury Division — South Carolina Securities Commissioner: tangential to resolution, no directional effect.
-
→ neutral ○ Context2026-01-28 - Attorney General Bonta Joins Multistate Coalition Condemning U.S. DOJ Threats Against Minnesota
Multistate AGs condemn DOJ threats; this concerns federal-state enforcement politics but gives no direct signal on DEA's rescheduling decision.
-
→ neutral ○ ContextAG Campbell Secures Agreement With Trump Administration Preventing Further Delays In Medical And Public Health Research
Office of the Attorney General — Massachusetts Office of the Attorney General Consumer Advocacy & Response Division: tangential to resolution, no directional effect.
Resolution criteria
This market will resolve to 'Yes' if marijuana is rescheduled down from Schedule I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to 'No'. The primary resolution source will be official information from the U.S. government, however a consensus of credible reporting will also be used. Note: In April 2026, FDA-approved marijuana products and state-licensed medical cannabis were moved to Schedule III under President Trump's executive order. This market specifically tracks whether recreational marijuana (currently Schedule I) is rescheduled. If the DEA reschedules only specific cannabinoids or derivatives without reclassifying marijuana as a whole, that does not qualify. A DEA administrative hearing on full rescheduling is scheduled to begin June 29, 2026.